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Commentary
Improving “research translation” has become 
a top priority of government agencies. In 
2003, the National Institute of Environmental 
Health Sciences (NIEHS) formalized 
research translation with the requirement 
of Community Outreach and Translation 
Cores at each of the Centers for Children’s 
Environmental Health and Disease Prevention 
Research. The NIEHS defines translation 
as the process of using basic research to 
inform “intervention and prevention meth-
ods to enhance awareness among commu-
nities, health care professionals, and policy   
makers of environmentally related diseases 
and health conditions” (NIEHS Division of 
Extramural Research and Training 2006). It 
has become clear that effective research trans-
lation involves collaboration among scientists, 
government officials, and individuals or com-
munities affected by   environmental issues.
The phrase “research translation” is 
ambiguous and often is used loosely to refer 
to the communication of research findings to 
professional audiences outside university or 
government research laboratories, such as risk 
assessors, pharmaceutical companies, and con-
gressional aides, rather than to lay communi-
ties facing environmental problems. In some 
cases, general research translation has displaced 
direct community outreach. For exam-
ple, although the NIEHS Superfund Basic 
Research Program (SBRP) once encouraged 
a Community Outreach Core, this remains 
optional for program applications, whereas the 
Research Translation Core is mandatory.
We describe the consensus confer-
ence model as one strategy for translat-
ing basic research in a way that overcomes 
social and technical barriers and thus allows 
us to include lay communities in the trans-
lation mix. The consensus conference pro-
cess was used to educate and elicit input from   
members of the lay public on the scientifically 
complex topic of human biomonitoring for 
environmental chemicals. In this commen-
tary we highlight what the process entails and 
report the findings our consensus conference 
lay panel released on human biomonitoring 
programs and their subsequent use by policy 
makers. The consensus conference project is a 
component of the Research Translation Core 
of the Boston University (BU) SBRP. The 
core carries out programs to systematically 
reduce barriers to effective research transla-
tion. With this project, we adopt a view of 
research translation that includes translating 
basic research to end users and perspectives 
from the lay public (beyond the bench) back 
into public health and research practice, a 
process we refer to as “simultaneous research 
translation.”
Background
Human biomonitoring, the practice of 
  measuring chemicals in human tissues and 
fluids, has advanced dramatically over the 
last decade (Stokstad 2004; Suk et al. 1996). 
Clinicians, researchers, government agencies, 
and environmental health advocacy groups 
now employ the technology for a variety of 
purposes. For example, the Centers for Disease 
Control and Prevention (CDC) conducts 
routine biomonitoring surveillance of the 
population through the National Health and 
Nutrition Examination Survey (NHANES) 
program. States are increasingly considering 
biomonitoring surveillance programs of their 
own. California passed legislation establish-
ing the first of these in September 2006, and 
Minnesota followed in May 2007. Indiana, 
New York, and Washington State also have 
introduced similar legislation.
Biomonitoring is a topic that has sparked 
some controversy, including concerns about 
the interpretation of biomonitoring results 
and whether and how such results should be 
communicated to the public and to research 
participants (Brody et al. 2007; Paustenbach 
and Galbraith 2006; Schmidt 2006). In 2006, 
the National Research Council (NRC) pub-
lished a report representing 2 years of delib-
eration by a panel of experts on the scientific 
and ethical challenges of human biomonitor-
ing (NRC 2006). Industry has also sponsored 
similar panels (Angerer et al. 2006; Bahadori 
et al. 2007; Bates et al. 2005). The voice of 
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the public, however, has been absent from 
these discussions. To begin to fill this gap, 
the BU School of Public Health (SPH) con-
vened a Danish-style consensus conference on 
biomonitoring in fall 2006.
In Denmark, consensus conferences are 
used to stimulate social debate and inform 
policy making on emerging science and tech-
nology issues. The process involves recruit-
ing a “lay panel” of residents, similar to jury 
duty in the United States. Their views are not 
meant to be representative of the lay public, 
but rather to highlight themes and concerns 
that exist among members of the general pub-
lic. The Danish government has convened 
consensus conferences on topics as varied as 
the regulation of genetically modified food, 
the use of new knowledge about the human 
brain, and electronic surveillance—topics that 
address a current controversy, require experts 
to clarify technical and scientific aspects, and 
are related to pending legislation or policy 
(Grundahl 1995; Steyaert and Lisor 2005).
The Boston Consensus Conference on 
Human Biomonitoring assembled 15 lay peo-
ple from the Boston area to consider ethical, 
legal, social, and scientific issues related to the 
practice of measuring chemicals in peoples’ 
bodies. We followed the Danish model, as 
described by Grundahl (1995), as closely as 
possible, while recognizing that the approach 
has been further developed over time. In 
addition to funding from the BU SBRP, the 
project was supported by an Environmental 
Justice grant awarded to BU SPH by NIEHS 
to provide education on the ethical issues and 
challenges related to conducting environmen-
tal health studies and to establish dialogue 
between scientists and community members.
Here we summarize the process of con-
vening the lay panel, present the panel’s find-
ings, and discuss how these findings have been 
received by policy makers, public health scien-
tists, and agencies. In particular, we highlight 
the unique contributions made by the lay 
panel to current thinking regarding govern-
ment biomonitoring surveillance programs, 
communication about biomonitoring study 
results, and ethics of right to know, privacy, 
and confidentiality.
Consensus Conference: 
Process and Preparation
The Boston Consensus Conference on Human 
Biomonitoring involved three weekend meet-
ings from October through December 2006. 
Over the first two weekends, the lay panel 
learned about biomonitoring through a facili-
tated curriculum of reading, expert testimony, 
and discussion. As they gained knowledge on 
the subject, the panelists began to identify and 
articulate key questions and concerns. During 
a third weekend, they posed these questions to 
a panel of experts and then summarized their 
findings and recommendations in a written 
Consensus Statement, which was presented in 
a public meeting.
The project was overseen by project staff 
at BU SPH, a team of professional facilitators 
with experience facilitating a prior consensus 
conference (Sclove 1997), and a steering com-
mittee [see Supplemental Material A (http://
www.ehponline.org/members/2008/0800037/
suppl.pdf)], which included seven experts from 
the fields of academia, government, industry, 
and advocacy. The steering committee’s role 
was to provide balanced oversight of the proj-
ect and a diversity of perspectives on the topic.
Assembling the lay panel. The 15 panel-
ists reflected the demographics of the City 
of Boston in terms of age, sex, race/ethnic-
ity, and income according to 2000 census 
data. Our goal of a 15-member panel was 
small enough to reach meaningful consensus 
in a limited time frame but large enough to 
allow for losing members to unforeseeable 
circumstances while maintaining a functional, 
diverse group. Occupation, education, and 
whether or not participants had children were 
also considered when selecting participants, 
who were recruited by placing ads in local 
newspapers and on Craigslist, posting fliers, 
and distributing postcards throughout the 
city. Everyone who responded with interest 
was contacted by phone and went through a 
preliminary screening. Those who remained 
interested and available on meeting dates 
were sent a questionnaire, which 65 people 
completed and returned. Participants were 
selected from this group to satisfy demo-
graphic balance, while also ensuring that none 
had prior experience with biomonitoring. 
The final panel [see Supplemental Material B 
(available online at http://www.  ehponline.
org/  members/2008/0800037/suppl.pdf)] was 
a diverse group from various Boston neigh-
borhoods and surrounding communities. 
Three participants had children < 13 years of 
age. Occupations included, among others, 
truck driver, attorney, youth detention center 
employee, and manager in a pharmaceutical 
company. Panel members who attended all 
sessions were equally compensated for their 
time and effort.
Educational materials and presen-
tations. Members of the lay panel were 
initially given a briefing paper, selected read-
ings, and presentations by experts in the 
field [Supplemental Material, Appendix A 
(available online at http://www.  ehponline.
org/  members/2008/0800037/suppl.pdf)]; 
additional information is available from the 
project Web site, www.biomonitoring06.
org). The first weekend, two BU SPH sci-
entists gave the panel a general overview 
of environmental health and the science of 
biomonitoring. The lay panel’s own ques-
tions and concerns determined the content 
of educational materials and presentations 
used for subsequent weekends. During the 
second weekend (3 weeks later), as questions 
from the lay panel became more focused, they 
heard from experts from both the national 
CDC surveillance program and the newly 
formed California surveillance program.
Deliberations. During the first weekend, 
the professional facilitators worked to establish 
trust and a commitment to the process among 
panel members and facilitators. The group 
agreed on a set of ground rules for commu-
nication and spent several hours defining the 
meaning of consensus: to reach consensus, all 
panel members needed to feel they could live 
with the decision and that their concerns had 
been voiced and heard by the group. Each 
time the facilitators presented a decision to 
the group, panel members closed their eyes 
and indicated their level of agreement by 
holding up one to four fingers, one indicat-
ing enthusiastic support and four disagree-
ment and blocking of consensus. From the 
outset the lay panel began to articulate their 
key questions about biomonitoring. Working 
in small groups with the facilitators, panel-
ists wrote questions and comments on index 
cards, tacked them to boards, arranged them 
by subject, and discussed them. At the end 
of the weekend, the facilitators organized the 
panel’s lengthy list of issues into 10 categories, 
for example, “ethics—confidentiality and dis-
closure” and “outreach, access, and control.”
During the second weekend, the lay panel 
further refined their questions and concerns 
about biomonitoring. After reviewing, adding 
to, and ranking issues identified the first week-
end, the group reached consensus on the key 
areas they wanted to consider. Using this new 
framework, small groups worked to delve more 
deeply into the issues and to clarify remaining 
questions. At the end of this process, the con-
ference room walls were covered with cards 
and poster boards. All were transcribed into 
a document, and the facilitators consolidated 
this into what would become the framework 
for the lay panel’s Consensus Statement.
Remaining questions from the second 
weekend informed selection of an expert panel 
for the third and final weekend meeting. With 
the help of the steering committee, project 
staff identified experts who could address the 
panels’ most pressing questions. Despite the 
short notice, expert participation was gener-
ous and enthusiastic. The expert panel took 
place on the Saturday of the final weekend 
[see Supplemental Material, Appendix A 
(available online at http://www.  ehponline.
org/  members/2008/0800037/suppl.pdf)]. 
Each expert gave a 20-min presentation that 
responded to questions of the lay panel, and 
presentations were followed by open discus-
sion. Lay panelists posed questions directly 
to the experts, or wrote them on cards that Boston Consensus Conference on Human Biomonitoring
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were read aloud by project staff. Members of 
the public in attendance were invited to ask 
questions once the lay panel finished asking 
their own.
After public discussion, the panelists were 
given time to take notes and reflect on the 
information. At the end of the day, the lay 
panel and facilitators met privately to review 
and discuss how the new information fit with 
their summary document from the second 
weekend. They added new opinions or ideas 
and inserted comments for group discussion. 
The facilitators then compiled all comments 
into a single document in preparation for the 
final working session.
The next day, the group finalized the 
Consensus Statement by reviewing the draft 
document in detail. They discussed each state-
ment one by one and worked to reach con-
sensus. In a few cases, the group could not 
reach consensus on the inclusion of a particu-
lar point or phrasing and agreed to exclude it 
from the final document. Each section of the 
statement was written by participants through 
a facilitated group process, with editing of the 
larger document by facilitators and project 
staff, and final review by the lay panel.
On the last day, the lay panel presented 
their findings at a public event. Panelists read 
from the Consensus Statement and answered 
questions from the audience in a lively ses-
sion. Those in attendance included repre-
sentatives from legislative offices and public 
health agencies (the offices of Massachusetts 
state senators, the newly elected governor’s 
transition team working group on energy and 
the environment, the Boston Public Health 
Commission, and the New Hampshire 
Department of Health and Human Services), 
academic researchers and students of environ-
mental health, community-based and environ-
mental advocacy organizations, a chemical 
industry trade association, and members of 
the press. The Consensus Statement and a 
17-min video on the project produced by BU 
SPH are available on the project’s Web site 
(www.biomonitoring06.org).
Findings: Lay Panel  
Consensus Statement on 
Human Biomonitoring 
In the preamble to the Consensus Statement, 
the panel recognizes biomonitoring as an 
important public issue that “hits close to 
home” for many of them. The statement iden-
tifies and makes recommendations on four 
areas the panel feels need further consideration 
as the practice of biomonitoring moves for-
ward: a) establishing responsible surveillance 
programs; b) using biomonitoring data to 
influence corporate and government behavior; 
c) educating the general public about biomon-
itoring; and d) addressing the issues of ethics, 
confidentiality, and disclosure.
Establishing responsible surveillance pro-
grams. The Consensus Statement supports 
the need for biomonitoring surveillance: 
By providing the ongoing, systematic collection, 
analysis, interpretation, and dissemination of 
biomonitoring data, surveillance programs dem-
onstrate to both the scientific community and the 
public that [chemicals are present in human bod-
ies] and potentially provide real information for 
public health intervention.
The panel hopes biomonitoring programs 
will encourage the allocation of more funds 
for studies on the health effects of exposure to 
chemicals.
The panel offers two noteworthy recom-
mendations. First, the panel recommends that 
biomonitoring surveillance oversight boards 
be composed of different stakeholder groups, 
including individuals from affected communi-
ties. As an example, the panel cites the advisory 
council for the Massachusetts lead surveillance 
program, which includes parents of children 
who live in low-income communities and may 
be adversely affected by lead exposure. Second, 
the panel believes that state-based biomonitor-
ing surveillance programs are a useful adjunct 
to the federal program. They argue that state 
programs may capture unique regional and 
local exposure patterns, and that because states 
are often the driving force behind important 
public health measures, state-specific infor-
mation enables more informed local decision 
making and consumer choices.
Using biomonitoring data to influence cor-
porate and government behavior. Throughout 
their deliberations, some members of the group 
expressed concern about accountability for 
chemical pollution, citing examples of corpo-
rate and government culpability for improp-
erly managed hazardous waste sites and other 
sources of chemical exposures. Many shared 
the desire to have biomonitoring data influence 
corporate and government behavior, particu-
larly by stimulating the development of “green 
chemistry” and “green production”: 
Our hope is that biomonitoring, by helping us 
understand which chemicals are increasing in 
our populations and guiding research on health 
outcomes, will lead to greater accountability and 
responsibility on the part of industry, . . . to more 
consistent compliance with regulations, and to 
advances in public health and medicine.
The panel considered how biomonitoring 
results may highlight a need to address exposure 
reduction, even in the face of uncertain health 
implications: 
Biomonitoring data showing an increasing trend in 
exposure to a chemical, even when the health effects 
are uncertain, should be treated in a precautionary 
manner that seeks to reduce or eliminate exposure.
Educating the general public about biomon-
itoring. The panel felt that educating the general 
public about biomonitoring was essential for 
achieving broad participation in biomonitor-
ing surveillance programs and research studies. 
They identified biomonitoring as a portal into 
the health care system, especially for communi-
ties who have historically lacked both access to 
and trust in health care providers: 
The experience of people in a biomonitoring pro-
gram can be both an opportunity and a risk for 
their attitude and trust in a health services sys-
tem that has not always served all members of our 
community equally.
The panel also recommended that bio-
monitoring information be shared with the 
public in broad, accessible public educa-
tion programs. The panel is aware that bio-
monitoring results may be misconstrued and 
that two groups may interpret the same infor-
mation differently, depending on their own 
interests and backgrounds: 
The information taught or communicated has 
to be precise, which includes conveying accurate 
information about what is known and not known 
about cause and effect of exposure to monitored 
chemicals. This can be difficult to do and take 
time; however, it’s an essential part of educating 
the general public in a way that does not raise 
inappropriate alarm.
Addressing the issues of ethics, confiden-
tiality, and disclosure. Concern about how 
individuals could be harmed by biomonitor-
ing results was the issue about which panel 
members had the strongest feelings. Although 
they were instructed about institutional review 
board requirements and mandated measures to 
protect human research subjects, they remained 
concerned about the potential for biomon-
itoring results to inadvertently or otherwise 
become attached to a person’s medical record 
without full consideration of the consequences 
for insurance or employment status. Among 
the ramifications noted in the Consensus 
Statement is the potential for the discovery of 
new information about a chemical’s toxicity 
long after a sample has been analyzed, which 
may render a once insignificant finding legally 
or medically significant. Importantly, panelists 
recommend that biomonitoring data be treated 
as a protected class of medical information: 
It is the consensus of the panel that information 
derived from biomonitoring, as with that from 
genetic testing and AIDS results reporting, should 
be statutorily exempted from being transmitted or 
shared with employers, insurers or others as part 
of the medical history, without the express written 
consent of the individual. Specifically, it is recom-
mended that legislation be enacted to ensure this.
Panelists also underscore that confiden-
tiality is critical to ensuring public trust in 
biomonitoring programs, and that it is imper-
ative that scientists and government officials 
consider—and better address—the unique 
confidentiality issues raised by biomonitoring.
Finally, the group asserts that study par-
ticipants should be able to decide whether or Nelson et al.
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not they want to receive their personal results, 
and that an important element of this report be 
inclusion of action steps for reducing exposure, 
when these are available.
Discussion
Thomas Burke (Risk Sciences and Public 
Policy Institute at John Hopkins Bloomberg 
School of Public Health, and chair of the 
NRC Biomonitoring Committee) said the 
lay panel clearly understood the issue and had 
moved biomonitoring forward. The Consensus 
Conference elicited lay people’s unique 
insights on biomonitoring that may be essen-
tial to the future development of biomonitor-
ing practice and policy. The project and its 
findings have been presented at numerous 
conferences and meetings, including those 
of the American Public Health Association, 
International Society for Environmental 
Epidemiology, Massachusetts Public Health 
Association, Minnesota Environmental Health 
Tracking and Biomonitoring Advisory Panel, 
the U.S. Environmental Protection Agency, 
and International Council of Chemical 
Associations. Articles have been published 
in a variety of forums, including trade and 
industry press (Dunn 2008; Nelson 2007a, 
2007b; Rizzuto 2007a, 2007b).
Some of the panel’s concerns reflect issues 
raised in other venues, such as the NRC report 
(NRC 2006) and deliberations about the 
California legislation. These include recom-
mendations for allowing participants to choose 
whether or not they want to receive their 
biomonitoring results; increased public educa-
tion on biomonitoring that is done in an objec-
tive, meaningful manner and that takes into 
account different educational and cultural back-
grounds; and the establishment of surveillance 
program oversight boards that include non-
expert community members. Although these 
issues are not new, expert opinion has been 
divided, particularly on the question of report-
ing back results to biomonitoring participants. 
The view of the lay public is another “data 
point” in these deliberations. For example, John 
Dreisig, a toxicologist with New Hampshire’s 
Public Health Laboratories, attended the lay 
panel’s presentation of their findings. New 
Hampshire has been working on biomonitor-
ing projects over the past several years to assess 
exposure to environmental contaminants such 
as arsenic and mercury, with grant funding 
from the CDC. Dreisig said the lay panel’s con-
sensus on the importance of reporting biomoni-
toring results to study participants affirmed his 
own program’s commitment to communicating 
individual results back to participants in their 
arsenic biomonitoring study. The Consensus 
Statement supported investing resources in the 
communication of findings and general educa-
tion of the public on study results (Dreisig J, 
personal communication).
The panel also provided recommendations 
and insights that have not, to our knowledge, 
been voiced in the literature or by expert 
panels. Notable among them is the recom-
mendation that an individual’s biomonitor-
ing results be statutorily exempted from their 
medical record unless express permission is 
granted. The concern about confidentiality 
was significant for the lay panel in ways that 
would affect participation in biomonitoring 
programs/studies.
The lay panel found that effective transla-
tion of biomonitoring results should involve 
carryover to corporate and government prac-
tices. From the beginning of their delibera-
tions, some vocal members of the panel were 
action-oriented and apt to raise solutions 
to environmental health problems without 
necessarily considering their relevance to 
biomonitoring. After being challenged by the 
facilitators to connect the issue of corporate 
and government accountability to the topic at 
hand, they articulated a conclusion about the 
potential for biomonitoring data to stimulate 
green chemistry, a view that is both novel and 
important. The panel concluded that upward 
trends in biomonitored compounds should 
trigger precautionary action even if health 
effects are uncertain. Although these concerns 
may be considered tangential by some pro-
fessionals, they are central to the purpose of 
biomonitoring for some lay panelists.
Other public health officials have also 
expressed to us the value of eliciting an 
informed lay perspective on these questions. 
In California, the first state to pass biomoni-
toring surveillance legislation, the Consensus 
Statement has been used as a tool for educat-
ing lay community members at workshops on 
designing the new state program. According 
to Amy Kyle (University of California–
Berkeley School of Public Health, personal 
communication),
The Consensus Statement is written in a different 
language than that used by scientists. It is acces-
sible to a different audience and is more readable 
and multidimensional than many other documents 
about biomonitoring.
The Consensus Conference also illumi-
nated the potential of the Danish model to 
involve the public in complex science and tech-
nology policy discussions. Each lay panelist 
brought his or her own background to the dis-
cussions of biomonitoring, and most had no 
prior knowledge about the technology. The lay 
panel’s findings offer a distinct and important 
viewpoint to add to those of academia, govern-
ment, and industry. As one member of the lay 
panel noted, “This is a good way to include 
the voices of ‘average folks’ and their uniquely 
relevant experiences in the policy making 
and public education process.” The strength 
of using a consensus-based model was also 
apparent. Coming to agreement on particular 
issues forced panel members to delve into the 
assumptions underlying their opinions, and to 
justify and question them in a way that does 
not happen in a majority-rules decision.
Dorothy Sussman (Division of Laboratory 
Sciences, National Center for Environmental 
Health, CDC) said the lay panel’s Consensus 
Statement reinforced the importance and 
value of public health agencies getting public 
input. CDC has since issued a communica-
tions research contract on public perceptions 
of biomonitoring. The Consensus Statement 
is also used by Sussman in her public presenta-
tions on the challenges of communicating 
biomonitoring surveillance results to the pub-
lic (Sussman D, personal communication).
As is the case with many valuable projects, 
this was a labor- and resource-intensive effort. 
Facilitation, staffing, and compensation of 
the lay panel for their time made up the bulk 
of the roughly $75,000 budget. Even with 
the advantage of insights from the project 
team involved with an earlier consensus con-
ference, the learning curve was steep for the 
organizers. Some of these challenges and over-
all cost would be alleviated if consensus con-
ferences were institutionalized and convened 
on a regular basis by an experienced team. 
We also hope that institutionalization of such 
a process would have the added benefit of 
increasing channels of communication with 
relevant policymakers. Unlike in Denmark, 
where consensus conferences are convened by 
the Danish Board of Technology, a govern-
ment agency that advises Danish Parliament 
on science and technology issues, the United 
States does not have the structure or prece-
dent for communicating a lay panel’s findings 
with policy makers. We were happy with our 
efforts to convey the panel’s recommenda-
tions to federal and state agencies considering 
biomonitoring, and to a broader audience of 
scientists and advocates, but believe the proj-
ect may have had even more impact on policy 
makers if a more formal relationship existed. 
Lay panel members invested a tremendous 
amount of time and energy into the process, 
and if they doubt their findings are given con-
sideration, we worry this could lead to skepti-
cism about participating in future consensus 
conferences or similar projects.
Conclusion
The consensus conference process demonstrated 
that the public can make informed recommen-
dations on complex scientific and technical 
information. During three weekends, panelists 
developed their own expertise and took knowl-
edge back to their communities. They posed 
insightful questions to experts and issued 
thoughtful responses to public questions. They 
were engaged with the issue, grasped the full 
range of uncertainties and complexities, and for-
mulated reasoned and useful recommendations.Boston Consensus Conference on Human Biomonitoring
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The deliberations and results of the 
Boston Consensus Conference on Human 
Biomonitoring demonstrate that the consensus 
conference process is effective in educating and 
engaging a small but diverse cross section of 
the public in scientific questions, one goal of 
research translation. It shows that the public is 
fully capable of understanding technical issues 
and making valuable contributions to discus-
sions about policy-relevant science and tech-
nology. More important, however, the process 
was effective at bringing perspectives of the 
public to bear on scientific research and pub-
lic health practice, an important element of 
simultaneous research translation. The lay pan-
el’s unique perspective and recommendations 
on biomonitoring surveillance, communica-
tion, and ethics are important for environ-
mental health scientists and all stakeholders 
involved in biomonitoring. Indeed, they have 
very practical implications for recruitment 
of and communication with participants in 
biomonitoring studies, and for the establish-
ment of the many state-level biomonitoring 
surveillance programs now being considered.
Research translation should be a recip-
rocally informative process that allows for 
mutual education, with products that are 
strengthened by the diversity of voices and 
perspectives that create them. We hope the 
success of this attempt to engage lay people 
on a complicated technical topic and gather 
their input will encourage others to use this 
model for public participation in science and 
technology policy making.
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